• Membership
  • Advert Rates
  • Careers
  • About Us
  • Contact Us
  • Digital Store
Tuesday, June 24, 2025
The Trumpet Newspaper Nigeria
No Result
View All Result
  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition
  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition
No Result
View All Result
The Trumpet Newspaper Nigeria
No Result
View All Result
ADVERTISEMENT
Home News

Twitter Adopts ‘Poison Pill’ Plan to Block Elon Musk From Increasing Stake

The Trumpet Nigeria by The Trumpet Nigeria
February 6, 2025
in News
Reading Time: 3 mins read
0
Elon Musk, Twitter set to accept Musk's original $43B offer

Elon Musk

0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on LinkedinShare on WhatsAppShare on Pinterest

Twitter Inc. moved to prevent Elon Musk from significantly increasing his stake, a day after he unveiled a $43 billion unsolicited takeover bid for the social-media company.

The company on Friday adopted a so-called poison pill that makes it difficult for Mr. Musk to increase his stake beyond 15%. The billionaire founder of Tesla Inc. already owns a more-than 9% stake that he revealed earlier this month The Trumpet gathered.

ADVERTISEMENT

Poison pills, also called shareholder-rights plans, are legal manoeuvres that make it hard for shareholders to build their stakes beyond a set point by triggering an option for others to buy more shares at a discount. They are often used by companies that receive hostile takeover bids to block an unwanted suitor or buy time to consider their options.

Twitter said in a statement that the rights plan doesn’t prevent the company from engaging with potential acquirers or accepting a takeover bid if the board determines it is in the best interest of shareholders. It earlier confirmed it received Mr. Musk’s offer and is reviewing it.

The Wall Street Journal reported Thursday that Twitter was weighing installing a poison pill.

Mr. Musk may not be the only suitor for the company, as people familiar with the matter say that Thoma Bravo LP and other private-equity firms are now circling as well. But just because they are running the numbers doesn’t mean any of the firms will make a formal bid or that such a deal would come together.

Taking Twitter private would be no small feat; indeed, private-equity firms have explored and decided against it in the past. It would rank as one of the largest leveraged buyouts of all time, and Twitter doesn’t have the attributes of a typical LBO target like strong, stable cash flow. It is possible the buyout firms are also eyeing something short of a full takeover.

The New York Post earlier reported on Thoma Bravo’s interest in Twitter.

The private-equity firm, which specialises in the technology sector and manages roughly $100 billion, has been busy lately at a time of heightened buyout activity. It agreed to buy Anaplan Inc. for $10.7 billion in March, and SailPoint Technologies Inc. just days ago for $6.1 billion.

Mr. Musk, the billionaire founder of Tesla and privately held rocket company SpaceX, offered to pay $54.20 a share for Twitter and said that was his “best and final” bid. He has been criticising how Twitter moderates content, among other things, and briefly agreed this month to join its board before backing out.

His takeover offer has prompted speculation that a white-knight bidder such as another technology company or private-equity firm could surface as an alternative to a deal with the unpredictable and outspoken entrepreneur.

One possible outcome is that Twitter rejects Mr. Musk’s offer as too low but leaves the door open for him to return with a higher one, some of the people said. Mr. Musk said if the offer isn’t accepted, he will reconsider his position as a shareholder of the company. He also has said he has a Plan B, without detailing it.

One big question mark is how Mr. Musk would fund any deal. Though he is the world’s richest man, much of his wealth is tied up in Tesla shares and his offer didn’t have details on financing plans, which, like other aspects of the bid, is unusual. The Journal reported Thursday that Morgan Stanley would provide some debt financing for the bid and that Mr. Musk has received approaches from investors interested in backing it.

“There are a plethora of multibillionaires eager to fund Elon for whatever he wants to do,” said Joe Lonsdale, an Austin, Texas, venture capitalist and co-founder of Palantir Technologies Inc.

Read Also: NRC to Nigerians: You will Need NIN to Board Trains from May

One big name who doesn’t plan to put in money is Peter Thiel, a longtime associate of Mr. Musk dating back to their days as executives at PayPal Holdings Inc.

While Mr. Thiel, a fellow billionaire who has invested in several of Mr. Musk’s companies, has expressed to friends broad support for Mr. Musk’s anything-goes vision for Twitter, he doesn’t plan to back any bid, according to people familiar with his plans.

Existing Twitter shareholders supportive of Mr. Musk could also roll over their holdings into any deal.

But in a sign that Twitter’s investors overall appear less than enthusiastic over Mr. Musk’s bid, the company’s shares closed down nearly 2% Thursday at $45.08. The market was closed Friday for the Good Friday holiday.

Tags: Elon MuskTwitter
Previous Post

YOSN organises a capacity-building tech programme for 500 Nigerian Youths

Next Post

Scientists discover cure for heart attacks

The Trumpet Nigeria

The Trumpet Nigeria

Next Post
Scientists

Scientists discover cure for heart attacks

About The Trumpet

The Trumpet is a Nigerian based national news media, owned, trademarked and operated by Elomaz Communications Limited with headquarters in FCT-Abuja and regional offices in Lagos and Delta States

Follow Us

Resources

  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition

Recent News

Iran denies violating ceasefire as Israel orders 'powerful strikes' on Tehran

Iran denies violating ceasefire as Israel orders ‘powerful strikes’ on Tehran

June 24, 2025
US military base in Qatar, Middle East, Al-Udeid, shelter in place

What to know about Iran’s attack on US base in Qatar

June 24, 2025
  • Cookie Policy
  • Disclaimer
  • Contact us
  • About Us
  • Cookie Policy
  • Disclaimer
  • Contact us
  • About Us

© 2025 The Trumpet News Papers - Developed by VIS Nigeria.

No Result
View All Result
  • Home
  • News
    • Breaking News
    • Headlines
    • Metro
    • Health
  • Politics
  • Business
    • Ecommerce
    • Economy
    • Start-up
  • Entertainment
  • Sports
  • Opinion
    • Religion
    • Columnists
    • Contributors
    • Editorial
  • Global
    • Climate
    • Culture
    • Tourism
    • Technology
    • Weather
    • Social Media
  • e-Edition

© 2025 The Trumpet News Papers - Developed by VIS Nigeria.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Go to mobile version
Verified by MonsterInsights